These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24786317)

  • 1. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model.
    Winkler S; Borkham-Kamphorst E; Stock P; Brückner S; Dollinger M; Weiskirchen R; Christ B
    Exp Cell Res; 2014 Aug; 326(2):230-9. PubMed ID: 24786317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation.
    Pelz S; Stock P; Brückner S; Christ B
    Exp Cell Res; 2012 Feb; 318(3):276-87. PubMed ID: 22108588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of NASH with human mesenchymal stem cells in the immunodeficient mouse.
    Winkler S; Christ B
    Methods Mol Biol; 2014; 1213():51-6. PubMed ID: 25173373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
    Ezquer M; Ezquer F; Ricca M; Allers C; Conget P
    J Hepatol; 2011 Nov; 55(5):1112-20. PubMed ID: 21356258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fat option for the pig: hepatocytic differentiated mesenchymal stem cells for translational research.
    Brückner S; Tautenhahn HM; Winkler S; Stock P; Dollinger M; Christ B
    Exp Cell Res; 2014 Feb; 321(2):267-75. PubMed ID: 24200501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal mesenchymal stem cells derived from human bone marrow can differentiate into hepatocyte-like cells in injured livers of SCID mice.
    Tao XR; Li WL; Su J; Jin CX; Wang XM; Li JX; Hu JK; Xiang ZH; Lau JT; Hu YP
    J Cell Biochem; 2009 Oct; 108(3):693-704. PubMed ID: 19693776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression.
    Jung Y; Diehl AM
    Dig Dis; 2010; 28(1):225-8. PubMed ID: 20460916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
    Seo KW; Sohn SY; Bhang DH; Nam MJ; Lee HW; Youn HY
    Cell Biol Int; 2014 Jan; 38(1):106-16. PubMed ID: 24115681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy.
    Ezquer F; Bahamonde J; Huang YL; Ezquer M
    Stem Cell Res Ther; 2017 Jan; 8(1):20. PubMed ID: 28129776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure.
    Moslem M; Valojerdi MR; Pournasr B; Muhammadnejad A; Baharvand H
    Cell Transplant; 2013; 22(10):1785-99. PubMed ID: 23394436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.
    Campard D; Lysy PA; Najimi M; Sokal EM
    Gastroenterology; 2008 Mar; 134(3):833-48. PubMed ID: 18243183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse white adipose tissue-derived mesenchymal stem cells gain pericentral and periportal hepatocyte features after differentiation in vitro, which are preserved in vivo after hepatic transplantation.
    Winkler S; Hempel M; Brückner S; Mallek F; Weise A; Liehr T; Tautenhahn HM; Bartels M; Christ B
    Acta Physiol (Oxf); 2015 Oct; 215(2):89-104. PubMed ID: 26235702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kato T; Okochi H; Ochiya T
    J Gastroenterol Hepatol; 2009 Jan; 24(1):70-7. PubMed ID: 18624899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
    J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.
    Aurich I; Mueller LP; Aurich H; Luetzkendorf J; Tisljar K; Dollinger MM; Schormann W; Walldorf J; Hengstler JG; Fleig WE; Christ B
    Gut; 2007 Mar; 56(3):405-15. PubMed ID: 16928726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy.
    Fouraschen SM; Pan Q; de Ruiter PE; Farid WR; Kazemier G; Kwekkeboom J; Ijzermans JN; Metselaar HJ; Tilanus HW; de Jonge J; van der Laan LJ
    Stem Cells Dev; 2012 Sep; 21(13):2410-9. PubMed ID: 22455365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.
    Ezquer F; Bruna F; Calligaris S; Conget P; Ezquer M
    World J Gastroenterol; 2016 Jan; 22(1):24-36. PubMed ID: 26755858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo.
    Aurich H; Sgodda M; Kaltwasser P; Vetter M; Weise A; Liehr T; Brulport M; Hengstler JG; Dollinger MM; Fleig WE; Christ B
    Gut; 2009 Apr; 58(4):570-81. PubMed ID: 19022918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
    López-Vicario C; González-Périz A; Rius B; Morán-Salvador E; García-Alonso V; Lozano JJ; Bataller R; Cofán M; Kang JX; Arroyo V; Clària J; Titos E
    Gut; 2014 Feb; 63(2):344-55. PubMed ID: 23492103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.